123 related articles for article (PubMed ID: 8923828)
1. Apparent cortisone reductase deficiency: a unique form of hypercortisolism.
Phillipov G; Palermo M; Shackleton CH
J Clin Endocrinol Metab; 1996 Nov; 81(11):3855-60. PubMed ID: 8923828
[TBL] [Abstract][Full Text] [Related]
2. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
4. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
5. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
[TBL] [Abstract][Full Text] [Related]
6. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
7. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
[TBL] [Abstract][Full Text] [Related]
8. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
[TBL] [Abstract][Full Text] [Related]
9. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
Finken MJ; Andrews RC; Andrew R; Walker BR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
[TBL] [Abstract][Full Text] [Related]
10. Cortisol metabolism in the postoperative period after cardiac surgery.
Vogeser M; Felbinger TW; Röll W; Jacob K
Exp Clin Endocrinol Diabetes; 1999; 107(8):539-46. PubMed ID: 10612485
[TBL] [Abstract][Full Text] [Related]
11. Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families.
Shackleton CH; Rodriguez J; Arteaga E; Lopez JM; Winter JS
Clin Endocrinol (Oxf); 1985 Jun; 22(6):701-12. PubMed ID: 3860318
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy.
Małunowicz EM; Romer TE; Urban M; Bossowski A
Horm Res; 2003; 59(4):205-10. PubMed ID: 12649576
[TBL] [Abstract][Full Text] [Related]
13. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
14. Effect of glucocorticoid excess on the cortisol/cortisone ratio.
Dötsch J; Dörr HG; Stalla GK; Sippell WG
Steroids; 2001 Nov; 66(11):817-20. PubMed ID: 11576621
[TBL] [Abstract][Full Text] [Related]
15. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
16. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1.
Jamieson A; Wallace AM; Andrew R; Nunez BS; Walker BR; Fraser R; White PC; Connell JM
J Clin Endocrinol Metab; 1999 Oct; 84(10):3570-4. PubMed ID: 10522997
[TBL] [Abstract][Full Text] [Related]
17. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
Remer T; Maser-Gluth C; Boye KR; Hartmann MF; Heinze E; Wudy SA
Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
[TBL] [Abstract][Full Text] [Related]
18. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase.
Rodin A; Thakkar H; Taylor N; Clayton R
N Engl J Med; 1994 Feb; 330(7):460-5. PubMed ID: 8289851
[TBL] [Abstract][Full Text] [Related]
19. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
20. Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics.
Santini DL; Lorenzo BJ; Koufis T; Reidenberg MM
Am J Hypertens; 1995 May; 8(5 Pt 1):516-9. PubMed ID: 7662229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
